As Moderna's search for African manufacturing site ramps up, Bancel answers criticism about donations
Years before the pandemic, Moderna’s CEO Stéphane Bancel had thoughts of using mRNA to fight neglected tropical diseases.
Now, while under the magnifying glass of the US government and public health organizations alike, his company will try to slide into the often-neglected area to help with Covid-19 vaccines too.
A week ago, Moderna announced that it would invest $500 million in an African manufacturing plant, though it didn’t say exactly where that would be. Bancel said Thursday in a call with Endpoints News that his team has narrowed the search down to a final list “between three and five countries,” that the company is currently assessing.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 148,400+ biopharma pros reading Endpoints daily — and it's free.